Autophagy Sciences Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2016

Location

Seoul South Korea

Primary Industry

Biotechnology

About

Based in Seoul, South Korea, and founded in 2016, Autophagy Sciences is a drug development company that uses autophagy technology to develop drugs and treatments for diseases that are difficult to treat. Autophagy technology refers to the mechanism for decomposing unnecessary or dysfunctional cells. The company has filed a patent for NASH (Non-Alcoholic Steatohepatitis) treatment. In 2020, the company has filed a phase I clinical trial. Autophagy Sciences researches and develops drugs and treatments using autophagy technology. Autophagy Sciences plans to develop various drugs and medical treatments to treat NASH (Non-Alcoholic Steatohepatitis), IBD (Inflammatory Bowel Disease), AMD (Age-related Macular Degeneration), and degenerative brain disease. The company is in the clinical stage of developing new drugs for NASH. The company has developed a new drug material known as AS-101 for NASH (Non-Alcoholic Steatohepatitis) and applied for a phase I clinical trial in December 2020. The company plans to develop treatments using autophagy technology as the medical experts predict that the NASH treatment market will reach KRW 30 trillion by 2026.

Current Investors

Industrial Bank of Korea, Kolon Investment, Cloud IB Investment

Request a demo to show more

Primary Industry

Biotechnology

Sub Industries

Biopharmaceuticals, Pharmaceutical Research & Development

Website

www.autophagysci.com

Verticals

HealthTech

Company Stage

Series A

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.